GlaxoSmithKline has supported the Cancer Research Institute across patient education and thought leadership, providing sponsorship for the CRI-CIMT-EATI-AACR International Cancer Immunotherapy Conference, inaugural Immunotherapy Patient Summit, and multi-year sponsorship of the Immunotherapy Patient Summit series. In addition, GSK has provided unrestricted support to advance the Cancer Research Institute mission.

*Immunotherapy results may vary from patient to patient.